BNC Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,115
Closed -$1.14M 115
2022
Q3
$1.14M Sell
14,115
-401
-3% -$36K 0.69% 47
2022
Q2
$1.3M Buy
14,516
+655
+5% +$66.4K 0.68% 47
2022
Q1
$1.54M Buy
13,861
+396
+3% +$41.8K 0.76% 40
2021
Q4
$1.39M Buy
13,465
+345
+3% +$40K 0.66% 45
2021
Q3
$1.65M Buy
13,120
+431
+3% +$55.8K 0.98% 33
2021
Q2
$1.57M Buy
12,689
+546
+4% +$68.6K 0.95% 34
2021
Q1
$1.43M Buy
12,143
+571
+5% +$66.9K 1.02% 33
2020
Q4
$1.36M Buy
11,572
+882
+8% +$97.1K 0.86% 38
2020
Q3
$1.11M Buy
+10,690
New +$1.07M 0.78% 37

Other funds holding MDT

BNC Wealth Management's MDT Position: Q4 2022 in Review

BNC Wealth Management sold out of Medtronic (MDT) in Q4 2022, closing a stake of 14,115 shares — an estimated $1.14M sold.

BNC Wealth Management first reported a position in MDT in Q3 2020 and held it in 9 quarters. The position peaked at $1.65M in Q3 2021. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • BNC Wealth Management reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
  • BNC Wealth Management sold 14,115 Medtronic shares in Q4 2022, an estimated $1.14M.
  • BNC Wealth Management first reported a position in Medtronic in Q3 2020 and held it in 9 quarters.
  • BNC Wealth Management's Medtronic position peaked at $1.65M in Q3 2021.
  • 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on BNC Wealth Management's 13F filing for Q4 2022, filed 23 Jan 2023.